EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Aptamer-functionalized nanomaterials (AFNs) for therapeutic management of hepatocellular carcinoma

Xiujuan Yin, Jing Rong, Min Shao, Saisai Zhang, Likang Yin, Zhenqiang He, Xiao Wang

Journal of Nanobiotechnology · 12.05.2024 · 22 (1)

DOI: 10.1186/s12951-024-02486-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Nanobiotechnology, online erschienen am 12.05.2024. Verfasst von Xiujuan Yin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Aptamers, Nucleotide, Nanostructures. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Major Research Foundation of Higher Education of Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) represents one of the deadliest cancers globally, making the search for more effective diagnostic and therapeutic approaches particularly crucial. Aptamer-functionalized nanomaterials (AFNs), an innovative nanotechnology, have paved new pathways for the targeted diagnosis and treatment of HCC. Initially, we outline the epidemiological background of HCC and the current therapeutic challenges. Subsequently, we explore in detail how AFNs enhance diagnostic and therapeutic efficiency and reduce side effects through the specific targeting of HCC cells and the optimization of drug delivery. Furthermore, we address the challenges faced by AFNs in clinical applications and future research directions, with a particular focus on enhancing their biocompatibility and assessing long-term effects. In summary, AFNs represent an avant-garde therapeutic approach, opening new avenues and possibilities for the diagnosis and treatment of HCC. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAptamers, NucleotideNanostructuresHumansAnimalsDrug Delivery SystemsAntineoplastic Agents

Stichwörter der Autor:innen

AptamerAptamer-functionalized nanomaterialsHepatocellular carcinomaMolecular imagingTargeted therapy

Substanzen

Aptamers, NucleotideAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China.
  • Clinical Medical College, Hebei University, Baoding, 071002, Hebei, China.
  • Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China. wangxiao@ahmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Major Research Foundation of Higher Education of Anhui Province

Zitieren

APA

Yin, X., Rong, J., Shao, M., Zhang, S., Yin, L., He, Z., & Wang, X. (2024). Aptamer-functionalized nanomaterials (AFNs) for therapeutic management of hepatocellular carcinoma. Journal of Nanobiotechnology, 22(1). https://doi.org/10.1186/s12951-024-02486-5

Vancouver

Yin X, Rong J, Shao M, Zhang S, Yin L, He Z, et al. Aptamer-functionalized nanomaterials (AFNs) for therapeutic management of hepatocellular carcinoma. Journal of Nanobiotechnology. 2024;22(1). doi:10.1186/s12951-024-02486-5

BibTeX
@article{Yin2024,
  author = {Yin, Xiujuan and Rong, Jing and Shao, Min and Zhang, Saisai and Yin, Likang and He, Zhenqiang and Wang, Xiao},
  title = {Aptamer-functionalized nanomaterials (AFNs) for therapeutic management of hepatocellular carcinoma},
  journal = {Journal of Nanobiotechnology},
  year = {2024},
  volume = {22},
  number = {1},
  doi = {10.1186/s12951-024-02486-5}
}
Kostenlos starten →